Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1

被引:54
作者
Sipsas, NV
Kalams, SA
Trocha, A
He, SQ
Blattner, WA
Walker, BD
Johnson, RP
机构
[1] MASSACHUSETTS GEN HOSP,AIDS RES CTR,CHARLESTOWN,MA 02129
[2] MASSACHUSETTS GEN HOSP,INFECT DIS UNIT,CHARLESTOWN,MA 02129
[3] HARVARD UNIV,SCH MED,CHARLESTOWN,MA 02129
[4] UNIV MARYLAND,SCH MED,INST HUMAN VIROL,BALTIMORE,MD 21201
[5] HARVARD UNIV,SCH MED,NEW ENGLAND REG PRIMATE RES CTR,SOUTHBOROUGH,MA 01772
关键词
human immunodeficiency virus-specific cytotoxic T lymphocyte; acquired immunodeficiency syndrome; human immunodeficiency virus-infected laboratory workers; immune response;
D O I
10.1172/JCI119221
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Characterization of the cytotoxic T lymphocyte (CTL) response against HIV-I has been limited by the use of target cells expressing viral proteins from laboratory isolates of HIV-1. This approach has favored identification of group-specific CTL responses and precluded assessment of the extent of type-specific CTL responses directed against HIV-1. Using cells expressing viral proteins from the HIV-1 IIIB strain, we performed a detailed characterization of HIV-1-specific CTL response in three laboratory workers accidentally infected with HIV-1 IIIB. Eight of the epitopes identified were group specific, lying in relatively conserved regions of Gag, reverse transcriptase, and envelope. Three type-specific epitopes were identified, two of them in highly variable regions of envelope. In longitudinal studies in one subject, seven different epitopes and five different restricting HLA class I alleles were identified, with a progressive increase in the number of CTL epitopes recognized by this subject over time. Our data demonstrate that type-specific CTL responses make up a significant proportion of the host cellular immune response against HIV-I and that a broadening of epitope specificity may occur.
引用
收藏
页码:752 / 762
页数:11
相关论文
共 61 条
[1]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[2]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[3]   RAPID DNA TYPING FOR HLA-C USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) - IDENTIFICATION OF SEROLOGICAL AND NON-SEROLOGICALLY DEFINED HLA-C ALLELES INCLUDING SEVERAL NEW ALLELES [J].
BUNCE, M ;
WELSH, KI .
TISSUE ANTIGENS, 1994, 43 (01) :7-17
[4]   GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED INDIVIDUALS - GAG EPITOPES ARE CLUSTERED IN 3 REGIONS OF THE P24GAG PROTEIN [J].
BUSEYNE, F ;
MCCHESNEY, M ;
PORROT, F ;
KOVARIK, S ;
GUY, B ;
RIVIERE, Y .
JOURNAL OF VIROLOGY, 1993, 67 (02) :694-702
[5]   BIOLOGY OF CLONED CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CLEARANCE OF VIRUS INVIVO [J].
BYRNE, JA ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1984, 51 (03) :682-686
[6]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[7]   VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[8]  
CLERICI M, 1991, J IMMUNOL, V146, P2214
[9]  
CULMANN B, 1991, J IMMUNOL, V146, P1560
[10]   BIOLOGICAL AND IMMUNOLOGICAL PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN - ANALYSIS OF PROTEINS WITH TRUNCATIONS AND DELETIONS EXPRESSED BY RECOMBINANT VACCINIA VIRUSES [J].
EARL, PL ;
KOENIG, S ;
MOSS, B .
JOURNAL OF VIROLOGY, 1991, 65 (01) :31-41